Back
Intel Corp. 10K Form
Buy
58
INTC
Intel Corp.
Last Price:
$46.52
Seasonality Move:
7.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-07-15 | 10K | INTC/Intel Corp. Annual |
| 2025-06-15 | 10K | INTC/Intel Corp. Annual |
| 2025-05-15 | 10K | INTC/Intel Corp. Annual |
| 2025-04-15 | 10K | INTC/Intel Corp. Annual |
| 2025-03-15 | 10K | INTC/Intel Corp. Annual |
| 2025-02-15 | 10K | INTC/Intel Corp. Annual |
Receive INTC News And Ratings
See the #1 stock for the next 7 days that we like better than INTC
INTC Financial Statistics
Sales & Book Value
| Annual Sales: | $52.9B |
|---|---|
| Cash Flow: | $800M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $22.88 |
| Price / Book: | 2.03 |
Profitability
| EPS (TTM): | -0.08190 |
|---|---|
| Net Income (TTM): | $26M |
| Gross Margin: | $18.4B |
| Return on Equity: | 0.02% |
| Return on Assets: | 0.01% |
Intel Corp. Earnings Forecast
Key Intel Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for INTC is 34.77%.
-
The Selling, General & Administrative Expenses for INTC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 26.06% of Revenue.
-
The Interest Expense is 4,196.15% of Operating Income.
-
The Net Earning history of INTC is 0.05% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 25 years.
Intel Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | INTC |
| CUSIP: | 458140 |
| Website: | intel.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 2.02 |
| Quick Ratio: | 1.31 |
Price-to-Earnings
| Trailing P/E Ratio: | 50.03 |
|---|---|
| Forward P/E Ratio: | 46.74 |
INTC Technical Analysis vs Fundamental Analysis
Buy
58
Intel Corp. (INTC)
is a Buy
Is Intel Corp. a Buy or a Sell?
-
Intel Corp. stock is rated a BuyThe current Intel Corp. [INTC] share price is $46.47. The Score for INTC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.